(Q33329207)

English

Phase II trial combining mitomycin with 5-fluorouracil, epirubicin, and cisplatin in recurrent and metastatic undifferentiated carcinoma of nasopharyngeal type

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Phase II trial combining mitomycin with 5-fluorouracil, epirubicin, and cisplatin in recurrent and metastatic undifferentiated carcinoma of nasopharyngeal type (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

phase II clinical trial

0 references

undifferentiated carcinoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

A Hasbini

1

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

R Mahjoubi

2

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

A Fandi

3

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

N Chouaki

4

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

A Taamma

5

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

P Lianes

6

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

H Cortès-Funes

7

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

S Alonso

8

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

J P Armand

9

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

E Cvitkovic

10

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

E Raymond

11

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

publication date

1 April 1999

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Annals of Oncology

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

421-425

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Relationship between the Epstein-Barr virus and undifferentiated nasopharyngeal carcinoma: Correlated nucleic acid hybridization and histopathological examination

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008342828496

7 January 2021

based on heuristic

inferred from DOI database lookup

Distant metastases of nasopharyngeal carcinoma: a study of 256 male patients

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008342828496

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemotherapy of metastatic and/or recurrent undifferentiated nasopharyngeal carcinoma with cisplatin, bleomycin, and fluorouracil

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008342828496

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II study of a combination of hydroxyurea, fluorouracil and mitomycin in previously treated squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008342828496

7 January 2021

based on heuristic

inferred from DOI database lookup

Induction chemotherapy with a new regimen alternating cisplatin, fluorouracil with mitomycin, hydroxyurea and bleomycin in carcinomas of nasopharynx or other sites of the head and neck region

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008342828496

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008342828496

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of chemotherapy in the management of nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008342828496

7 January 2021

based on heuristic

inferred from DOI database lookup

UCNT: chemocurable sometimes, but not very often

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008342828496

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemotherapy for recurrent or metastatic carcinoma of the nasopharynx. A review of the Princess Margaret Hospital experience

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008342828496

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemotherapy with cisplatin and continuous infusion of 5-fluorouracil and bleomycin for recurrent and metastatic nasopharyngeal carcinoma in Taiwan

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008342828496

7 January 2021

based on heuristic

inferred from DOI database lookup

Alternating chemo-radiotherapy with cisplatin and 5-fluorouracil plus bleomycin by continuous infusion for locally advanced undifferentiated carcinoma nasopharyngeal type

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008342828496

7 January 2021

based on heuristic

inferred from DOI database lookup

High Complete Response in Advanced Nasopharyngeal Carcinoma With Bleomycin, Epirubicin, and Cisplatin Before Radiotherapy

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008342828496

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I/II study of the CAPABLE regimen for patients with poorly differentiated carcinoma of the nasopharynx

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008342828496

7 January 2021

based on heuristic

inferred from DOI database lookup

Elimination of dose limiting toxicities of cisplatin, 5-fluorouracil, and leucovorin using a weekly 24-hour infusion schedule for the treatment of patients with nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008342828496

7 January 2021

based on heuristic

inferred from DOI database lookup

Nasopharyngeal carcinoma: a medical oncology viewpoint. The Gustave Roussy experience

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008342828496

7 January 2021

based on heuristic

inferred from DOI database lookup

Undifferentiated nasopharyngeal cancer (UCNT): current diagnostic and therapeutic aspects

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008342828496

7 January 2021

based on heuristic

inferred from DOI database lookup

Paclitaxel by three-hour infusion and carboplatin in advanced carcinoma of nasopharynx and other sites of the head and neck. A phase II study conducted by the Hellenic Cooperative Oncology Group

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008342828496

7 January 2021

based on heuristic

inferred from DOI database lookup

Activity of paclitaxel by three-hour infusion in Asian patients with metastatic undifferentiated nasopharyngeal cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008342828496

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1023/A:1008342828496

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33329207&oldid=1584711216"